Lymph node ratio better predicts disease-free survival in node-positive breast cancer than the number of positive lymph nodes

Journal of Clinical Oncology

Volumn 27, Issue 30, 2009, Pages

  Van Belle, Vanya ^a   Van Calster, Ben ^a   Wildiers, Hans ^a   Van Huffel, Sabine ^a   Neven, Patrick ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER SURVIVAL; DATA BASE; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE;

AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED;

EID: 77649094926     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.0044     Document Type: Letter

References (5)

1. Vinh-Hung V, Verkooijen HM, Fioretta G, et al: Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27:1062-1068, 2009
2. Cox DR: Regression models and life-tables (with discussion). J R Stat Soc Ser B 34:197-220, 1972
3. Heagerty P, Lumley T, Pepe M: Time-dependent roc curves for censored survival data and a diagnostic marker. Biometrics 56:337-344, 2000
4. Harrell F Jr, Klee K, Califf R, Pryor D, Rosati R: Regression modeling strategies for improved prognostic prediction. Stat Med 3:143-152, 1984
5. Sobin LH, Wittekind Ch (eds): TNM Classification of Malignant Tumours, (ed 6). Hoboken, NJ, Wiley, 2002